• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    munit-sa-m-2025-04-14

    Corbus Pharmaceuticals Starts Phase 1 Study of CRB-913 for Obesity

    GLOBENEWSWIRE

    Novo fails trial, linking obesity asset to psychiatric effects

    FIERCE BIOTECH

    Corbus Pharma Presents CRB-913 Data at ObesityWeek® 2024

    GLOBENEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.